Similar to CD93, CLEC14A was described as a key gene in a proposed ‘tumour angiogenesis signature’ determined by meta‐analysis of over 1000 tumour samples including breast, renal and head and neck cancers 154. The gene discussed is CLEC14A; the disease is neoplasm.